A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study.

Subjects

Subjects :

Humans
Male
Female
Treatment Outcome
Carcinoma, Non-Small-Cell Lung drug therapy
Carcinoma, Non-Small-Cell Lung pathology
Lung Neoplasms drug therapy
Lung Neoplasms pathology
Antibodies, Monoclonal, Humanized administration & dosage
Antibodies, Monoclonal, Humanized therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Antibodies, Monoclonal administration & dosage
Antibodies, Monoclonal therapeutic use
B7-H1 Antigen metabolism
B7-H1 Antigen antagonists & inhibitors

Details

Language :

English

ISSN :

1938-0690

Volume :

25

Issue :

3

Database :

MEDLINE

Journal :

Clinical lung cancer

Publication Type :

Academic Journal

Accession number :

38584069

Full Text :

https://doi.org/10.1016/j.cllc.2024.03.003